Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24029621 | 0.92 | SLC5A1 (0.78) | SLC5A1SLC5A2 | |
| SCHEMBL29474368 | 0.92 | SLC5A1 (1.00) | SLC5A1SLC5A2 | |
| SCHEMBL21028738 | 0.92 | SLC5A1 (1.00) | SLC5A1SLC5A2 | |
| SCHEMBL15741132 | 0.92 | SLC5A1 (1.00) | SLC5A1SLC5A2 | |
| SCHEMBL24029638 | 0.91 | SLC5A1 (0.88) | SLC5A1SLC5A2 | |
| SCHEMBL26557550 | 0.91 | SLC5A1 (0.70) | SLC5A1SLC5A2 | |
| SCHEMBL24029872 | 0.91 | SLC5A1 (0.85) | SLC5A1SLC5A2 | |
| SCHEMBL24029588 | 0.90 | SLC5A1 (0.83) | SLC5A1SLC5A2 | |
| SCHEMBL26806263 | 0.90 | SLC5A1 (0.83) | SLC5A1SLC5A2 | |
| SCHEMBL24029833 | 0.90 | SLC5A1 (0.75) | SLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331761-A1 | Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| US-20230331761-A1 | Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| WO-2021227440-A1 | A CLASS OF ARYL GLUCOSIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海喆邺生物科技有限公司 | 2021-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331761-A1 | Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof | SLC5A1, SLC5A2, SLC10A1 | SLC5A1 1/4885SLC5A2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.